1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Biliary Atresia Treatment Revenue 1.4 Market Analysis by Type 1.4.1 Global Biliary Atresia Treatment Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Drug Treatment 1.4.3 Surgery Treatment 1.5 Market by Application 1.5.1 Global Biliary Atresia Treatment Market Share by Application: 2020 VS 2026 1.5.2 Hospital 1.5.3 Clinic 1.5.4 Others 1.6 Coronavirus Disease 2019 (Covid-19): Biliary Atresia Treatment Industry Impact 1.6.1 How the Covid-19 is Affecting the Biliary Atresia Treatment Industry 1.6.1.1 Biliary Atresia Treatment Business Impact Assessment - Covid-19 1.6.1.2 Supply Chain Challenges 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products 1.6.2 Market Trends and Biliary Atresia Treatment Potential Opportunities in the COVID-19 Landscape 1.6.3 Measures / Proposal against Covid-19 1.6.3.1 Government Measures to Combat Covid-19 Impact 1.6.3.2 Proposal for Biliary Atresia Treatment Players to Combat Covid-19 Impact 1.7 Study Objectives 1.8 Years Considered 2 Global Growth Trends by Regions 2.1 Biliary Atresia Treatment Market Perspective (2015-2026) 2.2 Biliary Atresia Treatment Growth Trends by Regions 2.2.1 Biliary Atresia Treatment Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Biliary Atresia Treatment Historic Market Share by Regions (2015-2020) 2.2.3 Biliary Atresia Treatment Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Biliary Atresia Treatment Market Growth Strategy 2.3.6 Primary Interviews with Key Biliary Atresia Treatment Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Biliary Atresia Treatment Players by Market Size 3.1.1 Global Top Biliary Atresia Treatment Players by Revenue (2015-2020) 3.1.2 Global Biliary Atresia Treatment Revenue Market Share by Players (2015-2020) 3.1.3 Global Biliary Atresia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Biliary Atresia Treatment Market Concentration Ratio 3.2.1 Global Biliary Atresia Treatment Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Biliary Atresia Treatment Revenue in 2019 3.3 Biliary Atresia Treatment Key Players Head office and Area Served 3.4 Key Players Biliary Atresia Treatment Product Solution and Service 3.5 Date of Enter into Biliary Atresia Treatment Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Biliary Atresia Treatment Historic Market Size by Type (2015-2020) 4.2 Global Biliary Atresia Treatment Forecasted Market Size by Type (2021-2026) 5 Biliary Atresia Treatment Breakdown Data by Application (2015-2026) 5.1 Global Biliary Atresia Treatment Market Size by Application (2015-2020) 5.2 Global Biliary Atresia Treatment Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Biliary Atresia Treatment Market Size (2015-2020) 6.2 Biliary Atresia Treatment Key Players in North America (2019-2020) 6.3 North America Biliary Atresia Treatment Market Size by Type (2015-2020) 6.4 North America Biliary Atresia Treatment Market Size by Application (2015-2020) 7 Europe 7.1 Europe Biliary Atresia Treatment Market Size (2015-2020) 7.2 Biliary Atresia Treatment Key Players in Europe (2019-2020) 7.3 Europe Biliary Atresia Treatment Market Size by Type (2015-2020) 7.4 Europe Biliary Atresia Treatment Market Size by Application (2015-2020) 8 Asia-Pacific 8.1 Asia-Pacific Biliary Atresia Treatment Market Size (2015-2020) 8.2 Biliary Atresia Treatment Key Players in Asia-Pacific (2019-2020) 8.3 Asia-Pacific Biliary Atresia Treatment Market Size by Type (2015-2020) 8.4 Asia-Pacific Biliary Atresia Treatment Market Size by Application (2015-2020) (2015-2020) (2015-2020) 9 Key Players Profiles 9.1 AstraZeneca 9.1.1 AstraZeneca Company Details 9.1.2 AstraZeneca Business Overview and Its Total Revenue 9.1.3 AstraZeneca Biliary Atresia Treatment Introduction 9.1.4 AstraZeneca Revenue in Biliary Atresia Treatment Business (2015-2020)) 9.1.5 AstraZeneca Recent Development 9.2 Daiichi Sankyo 9.2.1 Daiichi Sankyo Company Details 9.2.2 Daiichi Sankyo Business Overview and Its Total Revenue 9.2.3 Daiichi Sankyo Biliary Atresia Treatment Introduction 9.2.4 Daiichi Sankyo Revenue in Biliary Atresia Treatment Business (2015-2020) 9.2.5 Daiichi Sankyo Recent Development 9.3 Eisai 9.3.1 Eisai Company Details 9.3.2 Eisai Business Overview and Its Total Revenue 9.3.3 Eisai Biliary Atresia Treatment Introduction 9.3.4 Eisai Revenue in Biliary Atresia Treatment Business (2015-2020) 9.3.5 Eisai Recent Development 9.4 Johnson & Johnson 9.4.1 Johnson & Johnson Company Details 9.4.2 Johnson & Johnson Business Overview and Its Total Revenue 9.4.3 Johnson & Johnson Biliary Atresia Treatment Introduction 9.4.4 Johnson & Johnson Revenue in Biliary Atresia Treatment Business (2015-2020) 9.4.5 Johnson & Johnson Recent Development 9.5 Novartis 9.5.1 Novartis Company Details 9.5.2 Novartis Business Overview and Its Total Revenue 9.5.3 Novartis Biliary Atresia Treatment Introduction 9.5.4 Novartis Revenue in Biliary Atresia Treatment Business (2015-2020) 9.5.5 Novartis Recent Development 9.6 Pfizer 9.6.1 Pfizer Company Details 9.6.2 Pfizer Business Overview and Its Total Revenue 9.6.3 Pfizer Biliary Atresia Treatment Introduction 9.6.4 Pfizer Revenue in Biliary Atresia Treatment Business (2015-2020) 9.6.5 Pfizer Recent Development 10 Analyst's Viewpoints/Conclusions 11 Appendix 11.1 Research Methodology 11.1.1 Methodology/Research Approach 11.1.2 Data Source 11.2 Disclaimer 11.3 Author Details

List of Tables Table 1. Biliary Atresia Treatment Key Market Segments Table 2. Key Players Covered: Ranking by Biliary Atresia Treatment Revenue Table 3. Ranking of Global Top Biliary Atresia Treatment Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Biliary Atresia Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Drug Treatment Table 6. Key Players of Surgery Treatment Table 7. COVID-19 Impact Global Market: (Four Biliary Atresia Treatment Market Size Forecast Scenarios) Table 8. Opportunities and Trends for Biliary Atresia Treatment Players in the COVID-19 Landscape Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis Table 10. Key Regions/Countries Measures against Covid-19 Impact Table 11. Proposal for Biliary Atresia Treatment Players to Combat Covid-19 Impact Table 12. Global Biliary Atresia Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 13. Global Biliary Atresia Treatment Market Size by Regions (US$ Million): 2020 VS 2026 Table 14. Global Biliary Atresia Treatment Market Size by Regions (2015-2020) (US$ Million) Table 15. Global Biliary Atresia Treatment Market Share by Regions (2015-2020) Table 16. Global Biliary Atresia Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 17. Global Biliary Atresia Treatment Market Share by Regions (2021-2026) Table 18. Market Top Trends Table 19. Key Drivers: Impact Analysis Table 20. Key Challenges Table 21. Biliary Atresia Treatment Market Growth Strategy Table 22. Main Points Interviewed from Key Biliary Atresia Treatment Players Table 23. Global Biliary Atresia Treatment Revenue by Players (2015-2020) (Million US$) Table 24. Global Biliary Atresia Treatment Market Share by Players (2015-2020) Table 25. Global Top Biliary Atresia Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biliary Atresia Treatment as of 2019) Table 26. Global Biliary Atresia Treatment by Players Market Concentration Ratio (CR5 and HHI) Table 27. Key Players Headquarters and Area Served Table 28. Key Players Biliary Atresia Treatment Product Solution and Service Table 29. Date of Enter into Biliary Atresia Treatment Market Table 30. Mergers & Acquisitions, Expansion Plans Table 31. Global Biliary Atresia Treatment Market Size by Type (2015-2020) (Million US$) Table 32. Global Biliary Atresia Treatment Market Size Share by Type (2015-2020) Table 33. Global Biliary Atresia Treatment Revenue Market Share by Type (2021-2026) Table 34. Global Biliary Atresia Treatment Market Size Share by Application (2015-2020) Table 35. Global Biliary Atresia Treatment Market Size by Application (2015-2020) (Million US$) Table 36. Global Biliary Atresia Treatment Market Size Share by Application (2021-2026) Table 37. North America Key Players Biliary Atresia Treatment Revenue (2019-2020) (Million US$) Table 38. North America Key Players Biliary Atresia Treatment Market Share (2019-2020) Table 39. North America Biliary Atresia Treatment Market Size by Type (2015-2020) (Million US$) Table 40. North America Biliary Atresia Treatment Market Share by Type (2015-2020) Table 41. North America Biliary Atresia Treatment Market Size by Application (2015-2020) (Million US$) Table 42. North America Biliary Atresia Treatment Market Share by Application (2015-2020) Table 43. Europe Key Players Biliary Atresia Treatment Revenue (2019-2020) (Million US$) Table 44. Europe Key Players Biliary Atresia Treatment Market Share (2019-2020) Table 45. Europe Biliary Atresia Treatment Market Size by Type (2015-2020) (Million US$) Table 46. Europe Biliary Atresia Treatment Market Share by Type (2015-2020) Table 47. Europe Biliary Atresia Treatment Market Size by Application (2015-2020) (Million US$) Table 48. Europe Biliary Atresia Treatment Market Share by Application (2015-2020) Table 49. Asia-Pacific Key Players Biliary Atresia Treatment Revenue (2019-2020) (Million US$) Table 50. Asia-Pacific Key Players Biliary Atresia Treatment Market Share (2019-2020) Table 51. Asia-Pacific Biliary Atresia Treatment Market Size by Type (2015-2020) (Million US$) Table 52. Asia-Pacific Biliary Atresia Treatment Market Share by Type (2015-2020) Table 53. Asia-Pacific Biliary Atresia Treatment Market Size by Application (2015-2020) (Million US$) Table 54. Asia-Pacific Biliary Atresia Treatment Market Share by Application (2015-2020) Table 55. AstraZeneca Company Details Table 56. AstraZeneca Business Overview Table 57. AstraZeneca Product Table 58. AstraZeneca Revenue in Biliary Atresia Treatment Business (2015-2020) (Million US$) Table 59. AstraZeneca Recent Development Table 60. Daiichi Sankyo Company Details Table 61. Daiichi Sankyo Business Overview Table 62. Daiichi Sankyo Product Table 63. Daiichi Sankyo Revenue in Biliary Atresia Treatment Business (2015-2020) (Million US$) Table 64. Daiichi Sankyo Recent Development Table 65. Eisai Company Details Table 66. Eisai Business Overview Table 67. Eisai Product Table 68. Eisai Revenue in Biliary Atresia Treatment Business (2015-2020) (Million US$) Table 69. Eisai Recent Development Table 70. Johnson & Johnson Company Details Table 71. Johnson & Johnson Business Overview Table 72. Johnson & Johnson Product Table 73. Johnson & Johnson Revenue in Biliary Atresia Treatment Business (2015-2020) (Million US$) Table 74. Johnson & Johnson Recent Development Table 75. Novartis Company Details Table 76. Novartis Business Overview Table 77. Novartis Product Table 78. Novartis Revenue in Biliary Atresia Treatment Business (2015-2020) (Million US$) Table 79. Novartis Recent Development Table 80. Pfizer Company Details Table 81. Pfizer Business Overview Table 82. Pfizer Product Table 83. Pfizer Revenue in Biliary Atresia Treatment Business (2015-2020) (Million US$) Table 84. Pfizer Recent Development Table 85. Research Programs/Design for This Report Table 86. Key Data Information from Secondary Sources Table 87. Key Data Information from Primary Sources List of Figures Figure 1. Global Biliary Atresia Treatment Market Share by Type: 2020 VS 2026 Figure 2. Drug Treatment Features Figure 3. Surgery Treatment Features Figure 4. Global Biliary Atresia Treatment Market Share by Application: 2020 VS 2026 Figure 5. Hospital Case Studies Figure 6. Clinic Case Studies Figure 7. Others Case Studies Figure 8. Biliary Atresia Treatment Report Years Considered Figure 9. Global Biliary Atresia Treatment Market Size YoY Growth 2015-2026 (US$ Million) Figure 10. Global Biliary Atresia Treatment Market Share by Regions: 2020 VS 2026 Figure 11. Global Biliary Atresia Treatment Market Share by Regions (2021-2026) Figure 12. Porter's Five Forces Analysis Figure 13. Global Biliary Atresia Treatment Market Share by Players in 2019 Figure 14. Global Top Biliary Atresia Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biliary Atresia Treatment as of 2019 Figure 15. The Top 10 and 5 Players Market Share by Biliary Atresia Treatment Revenue in 2019 Figure 16. North America Biliary Atresia Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 17. Europe Biliary Atresia Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 18. Asia-Pacific Biliary Atresia Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 19. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018 Figure 20. AstraZeneca Revenue Growth Rate in Biliary Atresia Treatment Business (2015-2020) Figure 21. Daiichi Sankyo Total Revenue (US$ Million): 2019 Compared with 2018 Figure 22. Daiichi Sankyo Revenue Growth Rate in Biliary Atresia Treatment Business (2015-2020) Figure 23. Eisai Total Revenue (US$ Million): 2019 Compared with 2018 Figure 24. Eisai Revenue Growth Rate in Biliary Atresia Treatment Business (2015-2020) Figure 25. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018 Figure 26. Johnson & Johnson Revenue Growth Rate in Biliary Atresia Treatment Business (2015-2020) Figure 27. Novartis Total Revenue (US$ Million): 2019 Compared with 2018 Figure 28. Novartis Revenue Growth Rate in Biliary Atresia Treatment Business (2015-2020) Figure 29. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 30. Pfizer Revenue Growth Rate in Biliary Atresia Treatment Business (2015-2020) Figure 31. Bottom-up and Top-down Approaches for This Report Figure 32. Data Triangulation Figure 33. Key Executives Interviewed

AstraZeneca Daiichi Sankyo Eisai Johnson & Johnson Novartis Pfizer